Balaxi Pharmaceuticals Ltd. logo

Balaxi Pharmaceuticals Ltd. (BALAXI)

Market Closed
12 Dec, 10:00
XNSE XNSE
30. 06
-2.96
-8.96%
4.17B Market Cap
- P/E Ratio
2% Div Yield
1,498,573 Volume
- Eps
33.02
Previous Close
Day Range
29.55 36.49
Year Range
29.55 84
Want to track BALAXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BALAXI closed yesterday lower at ₹30.06, a decrease of 8.96% from Thursday's close, completing a monthly decrease of -14.11% or ₹4.94. Over the past 12 months, BALAXI stock lost -58.43%.
BALAXI is not paying dividends to its shareholders.
Balaxi Pharmaceuticals Ltd. has completed 1 stock splits, with the recent split occurring on May 30, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XNSE (INR).

BALAXI Chart

Similar

Max India Limited
191.4
-0.9%
Nova Agritech Ltd.
39.65
-0.23%
Lyka Labs Ltd
77.69
-0.8%
Nath Bio-Genes (India) Limited
153.3
+1.01%

Balaxi Pharmaceuticals Ltd. (BALAXI) FAQ

What is the stock price today?

The current price is ₹30.06.

On which exchange is it traded?

Balaxi Pharmaceuticals Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is BALAXI.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2%.

What is its market cap?

As of today, the market cap is 4.17B.

Has Balaxi Pharmaceuticals Ltd. ever had a stock split?

Balaxi Pharmaceuticals Ltd. had 1 splits and the recent split was on May 30, 2024.

Balaxi Pharmaceuticals Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
XNSE Exchange
INE618N01014 ISIN
India Country
- Employees
1 Jul 2022 Last Dividend
30 May 2024 Last Split
- IPO Date

Overview

Balaxi Pharmaceuticals Limited is a prominent entity primarily engaged in the international wholesale distribution of a diverse range of products, including pharmaceuticals, builders hardware, and fast-moving consumer goods (FMCG). The company boasts a widespread presence in several key regions, notably Africa, the Caribbean Islands, and Latin America. Originally established in the year 1942 and having its headquarters in Hyderabad, India, Balaxi Pharmaceuticals has evolved significantly over the decades. Initially known as Balaxi Ventures Limited, the company underwent a strategic rebranding in October 2020, adopting its current name to reflect its focused commitment towards the pharmaceutical sector. As a subsidiary of Balaxi Overseas Private Limited, it continues to expand its footprint, delivering essential products and services to a global clientele.

Products and Services

Balaxi Pharmaceuticals Limited offers a wide spectrum of products and services across various categories, including:

  • Pharmaceutical Products: The company is renowned for its comprehensive range of pharmaceutical products, covering several therapeutic areas. This includes a focus on essential treatments such as antibiotics for bacterial infections, analgesics for pain relief, anti-malaria medications for the prevention and treatment of malaria, among others. By providing a broad assortment of pharmaceuticals, Balaxi Pharmaceuticals aims to meet the healthcare needs of diverse populations in the regions they serve.
  • Biscuits: In addition to healthcare products, Balaxi Pharmaceuticals extends its offerings to include FMCG products like biscuits. These are marketed to cater to the consumer goods segment, providing quality snack options to its clientele across its operational territories.
  • Toothpaste: Alongside biscuits, the company also supplies toothpaste, further diversifying its FMCG portfolio. This product line aims to address the daily necessities of personal care, promoting oral health among consumers in various international markets.

Contact Information

Address: Maps Towers
Phone: 91 40 2355 5300